In this expert perspective from Retina 2026, Sharon Fekrat, MD, FACS, FASRS, discusses a real-world retrospective analysis of the Vestrum Health Retina Database of patients with retinal vein occlusion ...
New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...
– RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular edema – – Approval is based on two Phase III studies demonstrating ...
Leuven, April 23, 2015 - ThromboGenics NV (Euronext Brussels:THR), an integrated biopharmaceutical company focused on developing and commercializing innovative medicines for the treatment of ...
Please provide your email address to receive an email when new articles are posted on . The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary ...
Former Pakistan Prime Minister Imran Khan underwent a brief medical procedure after being diagnosed with retinal vein occlusion (RVO), a serious eye condition that blocks blood flow from the retina.
– If approved by the FDA, RVO would be Vabysmo’s third indication in addition to wet age-related macular degeneration (AMD) and diabetic macular edema (DME) – – Vabysmo is the first and only treatment ...
DelveInsight’s “Retinal Vein Occlusion Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It ...
PTI founder received successful treatment for right eye at PIMS Islamabad, diagnosed with retinal vein occlusion, discharged ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo ...
– Additional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate is in line with other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results